Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2000 1
2003 1
2004 1
2005 2
2006 2
2007 1
2008 1
2010 4
2011 3
2012 4
2013 19
2014 16
2015 7
2016 8
2017 13
2018 6
2019 6
2020 9
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

99 results
Results by year
Filters applied: . Clear all
Page 1
Cellular processes in sepsis.
Rudiger A, Stotz M, Singer M. Rudiger A, et al. Among authors: stotz m. Swiss Med Wkly. 2008 Nov 1;138(43-44):629-34. Swiss Med Wkly. 2008. PMID: 19005868 Free article. Review.
Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Seles M, Hutterer GC, Kiesslich T, Pummer K, Berindan-Neagoe I, Perakis S, Schwarzenbacher D, Stotz M, Gerger A, Pichler M. Seles M, et al. Among authors: stotz m. Int J Mol Sci. 2016 Apr 15;17(4):573. doi: 10.3390/ijms17040573. Int J Mol Sci. 2016. PMID: 27092491 Free PMC article. Review.
Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Cerk S, Schwarzenbacher D, Adiprasito JB, Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA, Pichler M. Cerk S, et al. Among authors: stotz m. Int J Mol Sci. 2016 Sep 6;17(9):1485. doi: 10.3390/ijms17091485. Int J Mol Sci. 2016. PMID: 27608009 Free PMC article. Review.
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Müller M, Posch F, Kiem D, Barth D, Horvath L, Stotz M, Schaberl-Moser R, Pichler M, Greil R, Jost PJ, Seeber A, Amann A, Schlick K, Gerger A, Riedl JM. Müller M, et al. Among authors: stotz m. Ther Adv Med Oncol. 2021 Sep 30;13:17588359211039930. doi: 10.1177/17588359211039930. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34616490 Free PMC article.
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Riedl JM, Posch F, Horvath L, Gantschnigg A, Renneberg F, Schwarzenbacher E, Moik F, Barth DA, Rossmann CH, Stotz M, Schaberl-Moser R, Pichler M, Stöger H, Greil R, Djanani A, Schlick K, Gerger A. Riedl JM, et al. Among authors: stotz m. Eur J Cancer. 2021 Jul;151:3-13. doi: 10.1016/j.ejca.2021.03.040. Epub 2021 May 2. Eur J Cancer. 2021. PMID: 33951545 Free article.
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Riedl JM, Schwarzenbacher E, Moik F, Horvath L, Gantschnigg A, Renneberg F, Posch F, Barth DA, Stotz M, Pichler M, Hatzl S, Fandler-Höfler S, Gressenberger P, Gary T, Jost PJ, Greil R, Ay C, Djanani A, Gerger A, Schlick K. Riedl JM, et al. Among authors: stotz m. Thromb Haemost. 2021 Jul 12. doi: 10.1055/a-1548-4847. Online ahead of print. Thromb Haemost. 2021. PMID: 34255340
99 results